Clinical presentation and outcome of Thai patients with chronic lymphocytic leukemia: Retrospective analysis of 184 cases

Asian Pacific Journal of Allergy and Immunology

Volumn 23, Issue 4, 2005, Pages 197-203

  Sriphatphiriyakun, Tharinee ^a   Auewarakul, Chirayu U ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; AGRICULTURAL WORKER; ANEMIA; ANOREXIA; ARTICLE; AUTOIMMUNE DISEASE; CANCER INCIDENCE; CANCER MORTALITY; CANCER STAGING; CAUSE OF DEATH; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONSULTATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FATIGUE; FEMALE; FEVER; GERIATRIC PATIENT; HEPATOMEGALY; HUMAN; INFECTION; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATIENT ATTITUDE; PROGNOSIS; SEX DIFFERENCE; SPLENOMEGALY; SURVIVAL TIME; THAILAND; THROMBOCYTOPENIA; WEIGHT REDUCTION; WESTERN HEMISPHERE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HEPATOMEGALY; HUMANS; INFECTION; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SPLENOMEGALY; SURVIVAL ANALYSIS; THAILAND; WEIGHT LOSS;

EID: 33645278108     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Flinn IW, Grever MR. Chronic lymphocytic leukemia. (Review). Cancer Treat Rev 1996; 96: 1-13.
2. Rozman C, Montserrat E. Chronic lymphocytic leukemia. N Engl J Med 1995; 333: 1052-7.
3. Cheson BD, Bennettt JM, Rai KR, et al. Guidelines for clinical protocols for chronic lymphocytic leukemia (CLL): recommendations of the NCI-sponsored Working Group. Am J Hematol 1988; 29: 15 2-5.
4. Montserrat E, Rozman C. Chronic lymphocytic leukemia: prognostic factors and natural history. Bailliere's Clinical Haematology 1993; 6:849-66.
5. Buyse ME, Staquet MJ, Sylvester RJ (eds). Cancer Clinical Trials: Methods and Practice. Oxford: Oxford University Press, 1992.
6. Suzuki H. Recent trends in the treatment and prognosis of adult leukemia with characteristics of patients in Japan: transition during the fifteen years from 1971 to 1985. Jpn J Clin Oncol 1989; 19: 338-47.
7. Hansen MM. Chronic lymphocytic leukemia clinical studies based on 189 cases followed for a long time. Scand J Haematol 1973; 18: 32-86.
8. Yavorkosky LL, Terebkova ZF, Nikulshin SV. B-chronic lymphocytic leukemia in Latvia: epidemiological aspects. Eur J Haematol 1993; 51: 214-7.
9. Pines A, Ben-Bassat I, Modan M, et al. Survival and prognostic factors in chronic lymphocytic leukemia. Eur J Haematol 1987; 38: 123-30.
10. Paolino W, Infelise V, Rossi M, et al. Chronic lymphoid leukemia. Clinical observation about its natural progression. Acta Haematol 1980; 63: 19-27.
11. Rozman C, Montserrat E, Feliu E, et al. Prognosis of chronic lymphocytic leukemia: A multivariate survival analysis of 150 cases. Blood 1982; 59: 1001-5.
12. Leavell B. Chronic leukemia: a study of the incidence and factors influencing the duration of life. Am J Med Sci 1938; 196: 329-40.
13. Pascucci LM. Chronic leukemia: statistical study of symptoms, duration of life, and prognosis. Radiology 1942; 39: 75-80.
14. Silver RT. The treatment of chronic lymphocytic leukemia. Seminars in Hematology 1969; 344-56.
15. Phillips E, Kempin S, Passe S, et al. Prognostic factors in chronic lymphocytic leukemia and their implications for therapy. Clinics in Haematology 1977; 6: 203-15.
16. Bernadou A, Bernard J, Bilski-Pasquier G, et al. A propos du pronostic des leucemies lymphoides chroniques. Annales de Medicine Interne (Paris) 1973; 124: 549-60.
17. Coeur P, Boissel JP, Rendu G, et al. La duree de survie dans la leucemie lymphoide chronique (etude de 336 observations par la methode actuarielle). Societe Francaise D'Hematologie, Mai 1970; 552-59.
18. Bethel TH. Lymphogenous (lymphatic) leukemia. JAMA 1942; 118: 95-9.
19. Osgood EE, Seaman AJ, Koler RD. Natural history and course of the leukemias. Proceeding of the Third National Cancer Conference Detroit, Michigan, 1956; 366-82.
20. Montserrat E. Presenting features and prognosis of chronic lymphocytic leukemia in young adult. Blood 1991; 78: 1545-51.
21. Gray JL, Jacops A, Block M. Bone marrow and peripheral blood lymphocytosis in the prognosis of chronic lymphocytic leukemia. Cancer 1974; 33: 169-78.
22. Catovsky D, Fooks J, Richards S, et al. Prognostic factors in chronic lymphocytic leukemia: The importance of age, sex and response to treatment in survival. Br J Haematol 1989; 72: 141-7.
23. Boggs D R, Sofferman S A, Wintrob M M, et al. Factors influencing the duration of survival of patients with chronic lymphocytic leukemia. Am J Med 1966; 10: 243-54.
24. Binet J L, Auguir A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981; 48:194-206.
25. Keating MJ, Chiorazzi N, Messmer B, et al. Biology and treatment of chronic lymphocytic leukemia. Hematology (ASH Educ Prog) 2003; 153-75.
26. Lin TS, Lucas MS, Byrd JC. Rituximab in B-cell chronic lymphocytic leukemia. Semin Oncol 2003; 30: 483-92.
27. Keating MJ, Flinn I, Jain V, et al. Therapeutic role of alemtuzumab (Campath-lH) in patients who failed fludarabine: results of a large international study. Blood 2002; 99: 1755-62.